Results 11 to 20 of about 19,007,438 (352)
The Lancet Rheumatology, 2021 BACKGROUND Systemic sclerosis is a connective tissue disease characterised by multiorgan fibrosis with an autoimmune background and poor prognosis. Although a few drugs have shown some efficacy in treating the disease, there remains a great unmet medical
S. Ebata +14 more
semanticscholar +1 more source
Validation of the Hidradenitis Suppurativa Investigator Global Assessment
JAMA dermatology, 2023 Key Points Question Is the Hidradenitis Suppurativa Investigator Global Assessment (HS-IGA) a valid end-point measure for clinical trials in patients with hidradenitis suppurativa (HS?) Findings In this secondary analysis of the UCB phase 2 randomized ...
A. Garg +10 more
semanticscholar +1 more source
HemaSphere, 2022 Acalabrutinib is a Bruton tyrosine kinase inhibitor approved for patients with chronic lymphocytic leukemia (CLL). ASCEND is the pivotal phase 3 study of acalabrutinib versus investigator’s choice of idelalisib plus rituximab (IdR) or bendamustine plus ...
P. Ghia +17 more
semanticscholar +1 more source
British Journal of Dermatology, 2022 The validated Investigator Global Assessment for Atopic Dermatitis (vIGA‐AD™) is a standardized severity assessment for use in clinical trials and registries for atopic dermatitis (AD).
E. Simpson +11 more
semanticscholar +1 more source
Comparative Reductions in Investigator-Reported and Adjudicated Ischemic Events in REDUCE-IT.
Journal of the American College of Cardiology, 2021 BACKGROUND REDUCE-IT (Reduction of Cardiovascular Events With Icosapent Ethyl-Intervention Trial) randomized statin-treated patients with elevated triglycerides to icosapent ethyl (IPE) or placebo. There was a significant reduction in adjudicated events,
P. Gaba +16 more
semanticscholar +1 more source
The Physician-Investigator Workforce: Looking Ahead.
Academic medicine : journal of the Association of American Medical Colleges, 2021 Support of the U.S. health professions investigator workforce is critically important to the continued advancement of health care nationally. Physician-investigators comprise one segment of this health professions investigator workforce, which also ...
D. Andriole, R. Wolfson
semanticscholar +1 more source
Oral Oncology, 2018 OBJECTIVES We report 2-year results from CheckMate 141 to establish the long-term efficacy and safety profile of nivolumab and outcomes by tumor PD-L1 expression in patients with recurrent or metastatic (R/M),platinum-refractory squamous cell carcinoma ...
R. Ferris +24 more
semanticscholar +1 more source
«OTHER» PERSONS AS PARTICIPANTS IN SECRET INVESTIGATORS (DETECTIVE) ACTIONS (CRIMINAL CONTROL)
Науково-інформаційний вісник Івано-Франківського університету права імені Короля Данила Галицького, 2023 Purpose. The purpose of the work is to study the current legislation that ensures the legality of secret investigative (search) actions. The author of this work substantiates the illegality of using the materials of secret investigative (search) actions ...
Lototskyi Mykhailo
doaj +1 more source
Conducting Clinical Research During the COVID-19 Pandemic: Investigator and Participant Perspectives
JMIR Public Health and Surveillance, 2020 As the medical landscape changes daily with the coronavirus disease (COVID-19) pandemic, clinical researchers are caught off-guard and are forced to make decisions on research visits in their ongoing clinical trials.
Prasad R. Padala, A. Jendro, K. Padala
semanticscholar +1 more source
Treatment expectations but not preference affect outcome in a trial of CBT and exercise for pain [PDF]
, 2017 The following are members of the MUSICIAN study team: Gary Macfarlane (Principal Investigator), John McBeth (Investigator), Deborah Symmons (Investigator), Karina Lovell (investigator), Philip Keeley (Investigator), Phil Hannaford (Investigator), Chrysa ...
Beasley, Marcus John +3 more
core +1 more source